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Abstract   
 The aim of this work was to investigate the uricemic and uricosuric 
activity of   the hydro alcoholic extract of Pentopetia androsaemifolia in 
experimentally induced hyperuricemic mice. Hyperuricemia was induced in 
the mice by intraperitoneal injection of potassium oxonate. Oral 
administration of the extract at doses 50 to 200 mg/kg reduce hyperuricemia 
from 218.78 ± 7.50 to 72.29 ± 16.88 mg/l (P< 0. 05). The same doses of 50 
to 200 mg/kg of the extract also reduce uricosuria from 125.4 ± 4.4 to 70 ± 
12.6 mg/l (p< 0.05). A direct correlation exists between plasma uric acid 
concentration and urine uric acid concentration (r = 0.99). The hypouricemic 
activity of the extract could be due to xanthine oxidase inhibition by the 
flavonoids present in the extract.  
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Introduction 
 Gout is a metabolic disease characterized by hyperuricemia, with a 
blood concentration superior to 420 µmol/L (70 mg/L) (Bardin, 2007; 
Merriman T.R., and Dalbeth, 2011). Beyond this concentration, sodium urate 
precipitates in tissues, particularly in joints, provoking inflammatory 
reactions (Prigent & Berets, 1992). Acute gout can disappear on its own 
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within a short time without treatment. Whereas in the chronic state, it can 
lead to damages in joints and end up to be a permanent polyarthritis 
(Edwards et al., 2011).   
 Treatment of gout can be symptomatic with nonsteroidal anti-
inflammatory drugs, or in reducing uricemia by inhibiting xanthine oxidase 
(Choi et al., 2005; Terkeltaub, 2003) or increasing uricosuria (Suresh & Das, 
2012). 
 In the semi desert zone of the south of Madagascar, the local 
community is herdsmen, and their main diet is beef. This population often 
suffers from joint problems, especially of the big toe. Drinking the beverage 
prepared with the leaves of Pentopetia androsaemifolia relieves the pain and 
reduces the edema. This field observation is the basis of our hypothesis, that 
this decoction may reduce uricemia or increase uricosuria. 
 
Materials and methods 
 The materials for this study were the leaves of Pentopetia 
androsaemifolia collected from the southern region of Madagascar in 
December 2015. 
 
Preparation of the extract 
 The leaves were dried in shade, aerated, at room temperature, and 
grounded. Five hundred grams of the powder were macerated 5 days in 5 
liters of ethanol-water mixture (60:40), at room temperature. This macerate 
was filtered using Whattman paper n°3, and the filtrate was evaporated to 
dryness under vacuum with a rotative evaporator Evapotec® at the 
temperature of 80°C. 
 
Animal used 
 Albino mice, Swiss strain, of both sexes, aged 8 weeks, weighing 200 
to 210 g were used during the experiments. The animals were bred in the 
animal house of the Laboratoire de Pharmacologie Générale, de 
Pharmacocinétique et de Cosmétologie (LPGPC) of the Science Faculty, 
University of Antananarivo, at a temperature of 22±2°C and kept under 
12h/12h light/dark cycle. They were fed with LFL 1040® pelleted feed and 
had water ad libitum. 
 The mice were experimentally induced hyperuricemic by intra-
peritoneal injection of potassium oxonate aqueous solution at the dose of 200 
mg/kg (Vogel et al., 2002; Huang et al., 2008). 
 BIOLAB® reagent made of 42µmol/l of potassium hexacyanoferrate, 
450 Ul of peroxidase, 0.150 mmol/l  of amino-antipyrine and 120 Ul  of 
uricase, was used to dosage the uric acid concentration in the samples.  
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Study of the extract effect on uricemia 
 The extract was dissolved in distilled water. The induced 
hyperyricemic animals were divided into 4 groups: one group served as 
control and 3 treated with the extract at 3 different doses. The control group 
received 10 ml/kg of distilled water, while the other groups were orally 
administered the extract at doses 50, 100, and 200 mg/kg respectively in 10 
ml/kg of distilled water (Vogel et al., 2002).   
 Two hours after, the maxillary vein of the animal was pinpricked 
with a sterile pin. The blood was collected in non-heparinized glass tube, and 
centrifuged for 10 minutes at 3000 rpm with EBA 3S® centrifuge (Elin et al., 
1982). 
 After centrifugation, 25 µl of supernatant were placed in glass tube 
containing 1 ml of BIOLAB® reagent. The mixture was left at room 
temperature for 5 minutes. 
 The concentration of uric acid in the samples was determined by 
colorimetric technic, using APUS ® colorimeter, at the wavelength λ = 520 
nm, and a standard solution provided with the reagent (Wang et al., 2010). 
 
Study of the extract effect  on uricosuria  
 A raw beef juice was prepared by mixing 250 g of beef and 250 ml of 
9‰ NaCl in a blender, used as source of purine. The extract was dissolved in 
this juice. All the animals were injected intra peritoneally with 200 mg/kg of 
potassium oxonate (Vogel, 2002; Huang et al., 2008). One hour after, the 
animals were divided into 4 groups; one group serving as control, and 3 
groups treated with the extract. The control group animals received 10 ml/kg 
of the beef juice while the 3 groups, were respectively administered by oral 
route the beef juice containing 50, 100, and 200 mg/kg of the extract in 10 
ml/kg (Vogel et al., 2002). 
 Afterwards, they were put individually in metabolism cages for 24 
hours. Their urine were collected, and centrifuged for 10 minutes at 3000 
rpm. The supernatant was recuperated, and 25 µl of it was placed in glass 
tube containing 1 ml of BIOLAB® reagent. The mixture was left at room 
temperature for 5 minutes. 
 After this reaction, the uric acid concentration in the samples was 
determined.  APUS ® colorimeter was used at the wavelength of λ = 520 
nm, and a standard provided with the reagent was used to determine the 
concentration of uric acid in the samples. 
 
Relation between uricemia and uricosuria 
 Linear regression was established to evaluate the relation between 
uricosuria, uricemia and the dosage of the extract.  
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Analysis and expression of results  
 Results were expressed as mean ± s.e.m. They were compared using 
the Student ‘t’ test. A value of P<0.05 was considered significant. 
 
Results 
Effect of the extract on uricemia and uricosuria  
 The uricemia and uricosuria of the induced hyperuricemic mice by 
intra peritoneal injection of potassium oxonate and treated with the alcoholic 
extract of P. androsaemifolia are inferior to those of the hyperuricemic 
control groups (P<0.05) (Table I). 
Table I. Variation of uricemia and uricosuria of hyperuricemic mice, induced by potassium 
oxonate 200 mg/kg injected i.p.  in the control group and treated with P. androsaemifolia 
alcoholic extract, administered by oral route, at the doses of 50, 100 and 200 mg/kg. (?̅? ± 
e.s.m; n = 5; *P< .05). 
Animals Control group Treated with extract dissolved in beef juice 
Dosage 
 (mg/kg) 
Beef juice 50 100 200 
Uricemia (mg/l) 227.89 ± 18.80 218.78 ± 7.50* 137.86 ± 30.42* 72.29 ±  16.88*  
Uricosuria  (mg/l) 148  ±  1.4 125.4  ±  4.4* 92.6  ±  10.1* 70 ± 12.6* 
The correlation between the uricemia and uricosuria variation is very high (r=0.99). 
 
Discussion 
 Mouse was used as experimental model in this experiment, because 
the urate elimination in mouse is similar to that of humans (Ding et al., 
2005). Injection of potassium oxonate by intra peritoneal route and the juice 
prepared with raw beef increase the uric acid concentration in the blood 
(Vogel et al., 2002; Fukunari et al., 2004; Wang et al., 2010). Meanwhile, 
uricemia and uricosuria in animals treated with the alcoholic extract of P. 
androsaemifolia diminished, compared to the control group. 
 The main route of elimination of uric acid is the urinary tract. The 
diminution of uricemia could be explained by the increasing of uricosuria. 
Meanwhile, in this experiment, within the dosages used, the two parameters 
variate in the same way; both of them diminish in the treated animals.  
 This result means that the extract reduces the uricosuria and uricemia 
at the same time. Which let us deduce that the decrease in the concentration 
of uric acid in the urine is due to the reduction of the plasma uric acid 
concentration. From this observation, we advance a hypothesis that the 
alcoholic extract of   P. androsaemifolia have diminished the plasma uric 
acid concentration by inhibiting its synthesis. The extract might inhibit the 
xanthine oxidase responsible for the synthesis of the uric acid (Zhifeng et al., 
2005; Huang et al., 2008). 
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Conclusion 
 Our results show that the alcoholic extract of Pentopetia 
androsaemifolia reduces both uricemia and uricosuria in hyperuricemic 
mice. This activity could be due to the inhibition of xanthine oxidase 
responsible for the synthesis of uric acid. 
 
References: 
1. Bardin, T. (2007). Epidémiologie de la goutte. Revue du rhumatisme, 
74: 147-149. 
2. Choi, H.K., Mount, D.B. & Reginato, A.M. (2005). Pathogenesis of 
gout. Ann. Int. Med., 143(7): 499-516.  
3. Ding, Z., Dai Y. & WANG, Z. (2005). Hypouricemic action of 
scopoletin arising from xanthine oxidase inhibition and uricosuric 
activity. Planta Medica, 71: 183-185.  
4. Elin, R.J., Johnson, E. & Chesler R. (1982). Four methods for 
determining uric acid. Clin. Chem., 28 (10): 2098-2100.  
5. Edwards, N.L., Sundy, J.S., Forsythe, A., Blume, S., Pan, F. & 
Becker, M.A. (1977). Work productivity loss due to flares in patients 
with chronic gout refractory to conventional therapy. J. Med. Econ., 
14: 10-5. 
6. Fukunari, A., Okamoto, K., Nishino, T., Eger, B.T.E., Pai E.F., 
Kamezawa, M., Yamada, I. & Kato N. (2004). Y-700[1-[3-cyano-4-
(2,2-dimethylpropoxy) phenyl]-1Hpyrazole-4-carboxylic acid] a 
potent xanthine oxido reductase inhibitor with hepatic excretion.  J. 
Pharmacol. Exp. Ther., 311 (2): 519-528. 
7. Huang, C. G., Shang, Y. J., Zhang, J. R., Li W. J. & Jiao B. H. 
(2008). Hypouricemic effect of phenyl propanoid glycosides 
acteoside of Scrophularia ningpoensis on serum uric acid levels in 
potassium oxonate – pretreated mice. 
8. Am. J. Chin. Med., 36 (1): 149-157. 
9. Merriman, T. R. & Dalbeth, N. (2010). Bases génétiques de 
l’hyperuricémie et de la goutte. Revue du rhumatisme 77: 328-334.  
10. Prigent, D. & Berets, O. (1992). Epidémiologie de la goutte et 
hyperuricémie: déductions physiopathologiques. Revue Médecine et 
armées, 7 (20): 585-589.  
11. Suresh, E. & Das, P. (2012). Recent advances in management of 
gout. Int. J. Med., 105 (5): 407-417. 
12. Terkeltaub, R.A. (2003). Gout. New Engl. J. Med., 349 (17): 1647-
1655. 
13. Vogel, H. G., Scholkens, B. A., Sandow, J., Muller, G. & Vogel W. 
F. (2002). 
European Scientific Journal December 2017 edition Vol.13, No.36 ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431 
 
 
345 
14. Drug discovery and evaluation: pharmacology assays. 2nd Ed. 
Springer Verlag, Germany, 112-113. 
15. Wang, C. P., Wang, X., Zhang, X., Shi, Y. W., Liu, L. & Kong, L. D. 
(2010). Morin improves urate excretion and kidney function through 
regulation of renal organic ion transporters in hyperuricemic mice. J. 
Pharm. Pharmac. Sci., 13 (3): 413-424. 
16. Zhifeng, Y., Fong, W.P. & Cheng, C. H. K.  (2005). The dual actions 
of morin (3,5,7,2,4-Pentahydroxyflavone) as a hypouricemic agent: 
uricosuric effect and xanthine oxidase inhibitory activity. J. 
Pharmacol. Exp. Ther., 316 (1): 170-171. 
  
